This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Graft protective effect and induction of CD4+Foxp3+ cell by Thrombomodulin on allograft arteriosclerosis in mice
Journal of Cardiothoracic Surgery Open Access 21 May 2018
-
G-protein coupled receptor 15 mediates angiogenesis and cytoprotective function of thrombomodulin
Scientific Reports Open Access 06 April 2017
-
Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation
Journal of Intensive Care Open Access 07 January 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Spitzer TR . Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893–898.
Maruyama I . Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation. Thoromb Haemost 1999; 82: 718–721.
Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 2007; 5: 31–41.
Schuepbach RA, Feistritzer C, Fernández JA, Griffin JH, Riewald M . Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Thromb Haemost 2009; 101: 724–733.
Serefhanoglu S, Goker H, Buyukasik Y, Turgut M, Sayinalp N, Haznedaroglu IC et al. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors. Ann Hematol 2009; 88: 667–671.
Myles T, Nishimura T, Yun TH, Nagashima M, Morser J, Patterson AJ et al. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J Biol Chem 2003; 278: 51059–51067.
Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel anti-inflammatory mechanism. J Clin Invest 2005; 115: 1267–1274.
Acknowledgements
This work was supported in part by Kochi University President's Discretionary Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ikezoe, T., Takeuchi, A., Taniguchi, A. et al. Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome. Bone Marrow Transplant 46, 616–618 (2011). https://doi.org/10.1038/bmt.2010.158
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.158
This article is cited by
-
Graft protective effect and induction of CD4+Foxp3+ cell by Thrombomodulin on allograft arteriosclerosis in mice
Journal of Cardiothoracic Surgery (2018)
-
Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis
Bone Marrow Transplantation (2017)
-
The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective function and prevents SOS in a murine model
Bone Marrow Transplantation (2017)
-
G-protein coupled receptor 15 mediates angiogenesis and cytoprotective function of thrombomodulin
Scientific Reports (2017)
-
Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes
Bone Marrow Transplantation (2016)